Clinical Trial Update: A Second Infusion (Early Reinfusion) of Tisagenlecleucel in Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia(B-ALL) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating a second, early reinfusion of tisagenlecleucel in children and young adults with B-cell acute lymphoblastic leukemia; study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Kymriah (tisagenlecleucel)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: B-cell Acute Lymphoblastic Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING